News

Santarus is seeking marketing approval of Zegerid capsules 20mg and 40mg, which according to the company is a proton pump inhibitor (PPI) in capsule formulation that treats symptoms

According to Mark Olfson, a psychiatric researcher at the New York State Psychiatric Institute, 80% of patients suffering from ADHD are treated with stimulant medications, and a majority

The new system is designed to manage the clinical trials process through web-based and automated workflow features. It provides real-time information sharing among project teams in an effort

The final results, expected in August, will be used for an application to the FDA to get permission to conduct a phase II trial of the drug in

The studies used rodent models of chronic Crohn’s disease and ulcerative colitis, `both also referred inflammatory bowel disease (IBD). The kappaB Decoy was shown to be efficiently delivered

The once-daily treatment can be used for Parkinson’s disease (PD) both as monotherapy in patients with early PD and as an adjunct treatment in moderate to advanced disease.

The new relationship is designed to provide Scirex with immediate access to well developed expertise in clinical investigation in India whilst giving Clinigene the opportunity to expand its

Akzo said the work conducted in partnership between its Organon unit and Pfizer has achieved such a significant developmental milestone that will result in a retroactive change in

The European Committee for Medicinal Products for Human Use (CHMP) has recommended the anti-cancer drug for the treatment of patients with locally advanced or metastatic non-small cell lung